Takeda Pharmaceutical Co Ltd (NYSE:TAK)

19.62
Delayed Data
As of 6:30pm ET
 -0.11 / -0.56%
Today’s Change
15.50
Today|||52-Week Range
21.61
+16.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Operating ActivitiesNet Income / Starting Line695.4M1.1B1.7B983.0M
 
 
 
 
 
Depreciation1.5B1.6B1.6B2.5B
 
 
 
 
 
Total Other Cash Flow50.1M-757.6M-211.6M-734.5M
 
 
 
 
 
Funds From Operations2.3B1.9B3.1B2.7B
 
 
 
 
 
Funds From/For Other Operating Expenses2.0B-509.4M-308.7M-23.4M
 
 
 
 
 
Net Cash Flow - Operating Activities221.2M2.4B3.4B2.7B
 
 
 
 
 
 
InvestingIncrease In Investments-333.3M-758.2M-799.9M-154.2M
 
 
 
 
 
Decrease In Investments470.3M695.1M367.6M586.5M
 
 
 
 
 
Capital Expenditures-406.2M-569.4M-604.6M-700.5M
 
 
 
 
 
Fixed Asset Disposal14.5M622.5M794.4M1.2B
 
 
 
 
 
Net Assets From Acquisitions -68.9M-5.4B-255.6M-26.7B
 
 
 
 
 
Other Investing - Uses-18.5M-191.7M0.00-68.3M
 
 
 
 
Other Investing - Sources0.00--117.3M647.9M
 
 
 
Net Cash Flow Investing-642.7M-6.1B-933.4M-25.7B
 
 
 
 
 
 
FinancingShort Term Borrowings-41.7K3.8B-3.6B3.3B
 
 
 
 
 
Long Term Borrowings1.2B2.4B3.0B25.0B
 
 
 
 
 
Long Term Debt Reduction-833.1M-1.8B-721.8M0.00
 
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-186.1M-213.5M-169.2M-10.6M
 
 
 
 
 
Common Dividends-1.2B-1.3B-1.3B-1.3B
 
 
 
 
 
Cash Dividends Paid - Total-1.2B-1.3B-1.3B-1.3B
 
 
 
 
 
Other Sources - Financing0.00--0.000.00--
Other Uses - Financing50.4M127.1M36.8M129.2M
 
 
 
 
 
Net Cash Flow - Financing-999.2M2.7B-2.9B26.9B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-277.1M-53.0M-41.2M-282.0M
 
 
 
 
 
 
Net Change In Cash-1.4B-964.4M-376.4M4.0B